checkAd
    Startseite > Aktien > Omega Therapeutics > Nachrichten
    Omega Therapeutics Aktie
    1,9600
     
    USD
    -9,68 %
    -0,2100 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,9500
     
    USD
    3.400 STK
    Geldkurs 10.05.24
    1,9600
     
    USD
    13.800 STK
    Briefkurs 10.05.24
    ISIN: US68217N1054 · WKN: A3CWDR · SYM: OMGA · USA

    Neueste Nachrichten

    Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
    08.05.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
    06.05.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
    23.04.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
    09.04.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
    28.03.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
    06.03.24 · globenewswire · Omega Therapeutics
    Behandlung von Fettleibigkeit: Novo Nordisk: Revolution in der Fettleibigkeitsbehandlung lässt Aktien explodieren!
    04.01.24 · wallstreetONLINE NewsUpdate · Omega Therapeutics
    Behandlung von Fettleibigkeit: Novo Nordisk: Milliarden-Deal mit zwei Biotechs – Aktie verdoppelt sich!
    04.01.24 · wallstreetONLINE Redaktion · Omega Therapeutics
    Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    02.01.24 · globenewswire · Omega Therapeutics
    Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
    20.11.23 · globenewswire · Omega Therapeutics
    Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
    13.11.23 · globenewswire · Omega Therapeutics
    Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
    09.11.23 · globenewswire · Omega Therapeutics